ClinConnect ClinConnect Logo
Search / Trial NCT06218901

Association of Psychological Distress in Patients With Lung Cancer

Launched by SHANGHAI CHEST HOSPITAL · Jan 12, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how psychological distress, which includes feelings like anxiety and depression, affects patients with lung cancer who are receiving treatment. Researchers want to understand if reducing this psychological distress can help improve the effectiveness of cancer therapies, such as immunotherapy and targeted therapy. By studying the connection between emotional well-being and treatment outcomes, the goal is to find ways to help patients manage their mental health during their cancer journey.

To join the trial, participants must be at least 18 years old and have a confirmed diagnosis of lung cancer. They also need to be willing to sign a consent form to participate. The trial is currently recruiting participants, and those who take part will have the opportunity to contribute to important research that could lead to better care for future lung cancer patients. Overall, this study aims to improve both the mental and physical health of individuals facing this challenging diagnosis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Histologically proven diagnosis of lung cancer
  • 18 years of age or older
  • Ability to understand and the willingness to sign a written informed consent document
  • Exclusion Criteria:
  • Not willing to participate in this clinical trial

About Shanghai Chest Hospital

Shanghai Chest Hospital is a leading medical institution in China, renowned for its specialized expertise in respiratory and thoracic diseases. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and improving patient outcomes through innovative therapies and treatments. With a strong emphasis on collaboration and scientific rigor, Shanghai Chest Hospital actively engages in a variety of clinical trials aimed at exploring novel interventions and enhancing the understanding of pulmonary health. The hospital's state-of-the-art facilities and commitment to patient-centered care position it as a key player in the global research landscape.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported